How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Calcium Tablets for the Elderly Market
- By Product Form: Chewable Tablets, Effervescent Tablets, Coated Tablets, Extended Release Tablets, Oral Disintegrating Tablets
- By Calcium Source: Calcium Carbonate, Calcium Citrate, Calcium Lactate, Calcium Gluconate, Calcium Phosphate
- By Additional Nutrients: Calcium with Vitamin D, Calcium with Magnesium, Calcium with Zinc, Calcium with Vitamin K2, Calcium with Collagen
- By Distribution Channel: Pharmacies and Drugstores, Supermarkets and Hypermarkets, Online Retail, Specialty Health Stores, Hospitals and Clinics
- By End User: Elderly with Osteoporosis, Elderly with Osteopenia, Elderly with Vitamin D Deficiency, Elderly with Bone Fracture Risk, General Elderly Population
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Chewable Tablets leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 307 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Calcium Tablets for the Elderly Market report
A complete, evidence-based study - 12 chapters and 129 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bayer AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Pfizer Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →GlaxoSmithKline plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Amway Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Nature's Bounty Co.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Blackmores Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Church & Dwight Co. Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →NOW Foods
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →GNC Holdings Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Himalaya Global Holdings Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Swisse Wellness Pty Ltd
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Jamieson Laboratories
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Solgar Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Cargill
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Incorporated
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Chewable Tablets39.2
- Effervescent Tablets13.2
- Coated Tablets20.2
- Extended Release Tablets10.1
- Oral Disintegrating Tablets17.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bayer AG23.1
- Pfizer Inc.13.2
- GlaxoSmithKline plc8.9
- Amway Corporation11.5
- Nature's Bounty Co.5.4
- Abbott Laboratories9.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.2
- Europe21.1
- Asia Pacific20.8
- Latin America13.7
- Middle East and Africa9.3
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bayer AG | 90 | 78 | 79 | 95 | 93 | 79 | 86 |
| Pfizer Inc. | 69 | 87 | 79 | 73 | 72 | 68 | 75 |
| GlaxoSmithKline plc | 86 | 85 | 72 | 71 | 67 | 63 | 74 |
| Amway Corporation | 62 | 75 | 70 | 62 | 80 | 59 | 68 |
| Nature's Bounty Co. | 57 | 62 | 76 | 71 | 63 | 62 | 65 |
| Abbott Laboratories | 53 | 47 | 67 | 53 | 56 | 70 | 58 |
| Blackmores Limited | 59 | 48 | 53 | 57 | 55 | 50 | 54 |
| Church & Dwight Co. Inc. | 56 | 53 | 41 | 39 | 57 | 54 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bayer AG
- Pfizer Inc.
- GlaxoSmithKline plc
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bayer AG | ◐ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Pfizer Inc. | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| GlaxoSmithKline plc | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Amway Corporation | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Nature's Bounty Co. | ◐ | − | ◐ | ✓ | ◐ | − |
| Abbott Laboratories | ◐ | ◐ | ◐ | − | ◐ | − |
| Blackmores Limited | − | ◐ | ◐ | ◐ | − | ◐ |
| Church & Dwight Co. Inc. | ◐ | ◐ | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Challenger3
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Product Form in North America, then scale across Calcium Tablets for the Elderly Market — a $366M beachhead inside a $5.25B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Chewable Tablets
Best fit — highest urgency & budget in Product Form.
Effervescent Tablets
Strong fit — clear ROI and a fast path to value.
Coated Tablets
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Calcium Source & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Additional Nutrients
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Calcium Tablets for the Elderly Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Calcium Tablets for the Elderly Market is a high-growth opportunity — $1.71B by 2033, compounding at 10.3%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.3% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Calcium Source optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Calcium Tablets for the Elderly Market — a $2.26B market by 2033. Plan: grow share from 9.7% to 15.3%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.7% | 15.3% | Ahead |
| Revenue | $205M | $345M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 34.4% | 45.1% | On track |
| Customer retention | 84.0% | 96.3% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Calcium Source capability
A defensible second engine — invest in Calcium Source to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Calcium Source
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $47M capacity & capability investment
- Greenlight bolt-on M&A in Calcium Source
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentBehind
Sales deck · value proposition
Win the Calcium Tablets for the Elderly Market conversation — a $1.45B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Calcium Tablets for the Elderly Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Calcium Tablets for the Elderly Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Calcium Tablets for Pregnant Women Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportCalcium Tablet and Oral Liquid Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportCalcium Suppliment Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportCalcium Supplements with Vitamin D Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportCalcium Supplements for Kids Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportCalcium Supplements for Children Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportCalcium Supplement Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportCalcium Sulfate Bone Void Filler Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportCalcium Sennoside Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportCalcium Pyruvate Supplements Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportCalcium Pyruvate Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportCalcium Preparations Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy